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Timely diagnosis of hyponatremia is important for preventing potential morbidity and mortality as it is 
often an indicator of underlying disease. The most common cause of eurvolemic hyponatremia is the 
syndrome of inappropriate antidiuretic hormone (SIADH) secretion. Recent studies have demonstrated 
that proinflammatory cytokines such as interleukin (IL) 1β and IL-6 are involved in the development of 
hyponatremia, a condition that is associated with severe inflammation and is related to antidiuretic hormone 
(ADH) secretion. Serum sodium levels in hyponatremia are inversely correlated with the percentage of 
neutrophils, C-reactive protein, and N-terminal-pro brain type natriuretic peptide. Additionally, elevated 
levels of serum IL-6 and IL-1β are found in inflammatory diseases, and their levels are higher in patients with 
hyponatremia. Because it is significantly correlated with the degree of inflammation in children, hyponatremia 
could be used as a diagnostic marker of pediatric inflammatory diseases. Based on available evidence, we 
hypothesize that hyponatremia may be associated with inflammatory diseases in general. Understanding 
the mechanisms responsible for augmented ADH secretion during inflammation, monitoring patient sodium 
levels, and selecting the appropriate intravenous fluid treatment are important components that may lower 
the morbidity and mortality of patients in a critical condition.
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Introduction 
Hyponatremia, characterized by a serum sodium level that is less than 135 mEq/L, is 
one of the most commonly diagnosed electrolyte disorders in clinical medicine1). Although 
sodium deficiency leads to hyponatremia, this condition is more commonly caused by 
solute dilution resulting from excessive consumption of water. Severe hyponatremia, 
where serum sodium level falls below <125 mEq/L, occurs in approximately 3% of all 
hospitalized patients2). Additionally, a rapid drop in serum sodium levels to 110–120 
mEq/L leads to cerebral edema and brain herniation1). Since it is often an indicator of 
underlying disease, timely diagnosis of hyponatremia is of great importance in preventing 
potential morbidity and mortality3).
Approximately one-third of all hyponatremic patients are diagnosed with euvolemic 
hyponatremia, a condition commonly caused by the syndrome of inappropriate anti-
diuretic hormone secretion (SIADH)4). Under normal physiological conditions, antidiuretic 
hormone (ADH; also known as vasopressin) is secreted from the posterior pituitary gland 
in response to hyperosmolality in a process called osmotic ADH secretion. Osmotic ADH 
secretion leads to lowering of serum osmolality. Nonosmotic ADH secretion, associated 
with hypovolemia, pain, nausea, and use of certain drugs, also leads to hyponatremia5). 
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Although nonosmotic ADH secretion can be a normal biological 
response when caused by hypovolemia or low effective arterial 
blood volume, it can also be a symptom of SIADH3).
SIADH is characterized by euvolemia, high urinary sodium 
excretion (natriuresis), and elevated urine osmolality in the 
absence of diuretics. This syndrome is often associated with 
pituitary insufficiency, adrenal or renal dysfunctions, thyroid 
disorders, and edema3). ADH binds to the vasopressin-2 receptors 
in the renal collecting duct and stimulates a cyclic adenosine 
monophosphate–signaling cascade that leads to the insertion of 
preformed aquaporin-2 water channels into the apical plasma 
membrane, thereby resulting in the transcellular movement of 
water6).
Inflammation and hyponatremia: pathophysiological 
mechanisms
The development of hyponatremia is associated with vari-
ous inflammatory diseases including pneumonia, severe 
acute respiratory distress syndrome, tuberculosis, meningitis, 
encephalitis, human immunodeficiency virus infection, and 
malaria5). However, the pathophysiology of hyponatremia 
diagnosed under these inflammatory conditions remains elusive.
Recent research revealed that inflammatory cytokines such as 
IL-1β and IL-6 are involved in the development of hyponatremia 
associated with inflammatory conditions, and that this process 
is related to ADH secretion5,7,8). Landgraf et al.9) reported that IL-
1β stimulated both central and peripheral release of vasopressin 
in rats. In addition, Palin et al.10) reported that treatment of 
Wistar rats with lipopolysaccharide (LPS) resulted in reduced 
diuresis, elevated plasma arginine-vasopressin (AVP) levels, 
and an increase in the activity of AVP neurons. These authors 
also reported that a brain injection of IL-6 increased the activity 
of AVP neurons in a manner similar to that observed after 
peripheral LPS treatment. Accordingly, a brain injection of anti-
IL-6 antibodies prevented the LPS-induced activation of AVP 
neurons. Therefore, these authors suggested that IL-6 induces an 
early activation of AVP neurons in response to a LPS injection10). 
Most notably, Mastorakos et al.11) demonstrated that AVP levels 
were elevated 2 hours after IL-6 injection in all the six patients 
studied, suggesting that IL-6 activated the magno-cellular 
AVP-secreting neurons and that it may be involved in the 
development of an inappropriate AVP secretion syndrome.
Endothelial cells, smooth muscle cells, and blood brain 
barrier (BBB) pericytes secrete IL-6 in response to IL-1β and LPS 
stimulation12,13). Circulating IL-6 can be transported across the BBB 
or may simply diffuse across the BBB in the circumventricular 
organs5). Taken together, these findings suggest that inflammatory 
cytokines may regulate ADH secretion.
Inflammation and hyponatremia: clinical conditions
A number of studies have demonstrated that hyponatremia 
is associated with various inflammatory conditions7,14-18). Very 
frequently, meningitis has been identified to be a cause of 
SIADH15). Patwari et al.15) reported that SIADH was diagnosed 
in 22 of 60 patients (36.7%) with bacterial meningitis on 
admission, and found that SIADH is significantly correlated 
with the severity of meningeal inflammation. Although there 
are no reports that address the possible mechanisms underlying 
the relationship between SIADH and meningitis, we speculate 
that elevated levels of inflammatory cytokines such as IL-1β or 
IL-6, as observed in this disease, may lead to hyponatremia by 
augmenting ADH secretion.
Riikonen et al.16) showed that high C-reactive protein (CRP) 
levels were associated with low serum sodium concentrations 
and that an elevation in CRP levels is an early indicator of 
bacteremia in neutropenic children. Ohta and Ito7) also reported 
four cases of hyponatremia arising from SIADH that appeared to 
be related to inflammation. These authors reported the presence 
of increased concentrations of AVP and IL-6 in patients, and 
found that intravenous administration of IL-1β increased AVP 
and urinary sodium excretion. Therefore, IL-1β may have a 
significant role in the development of SIADH and hyponatremia 
associated with inflammation7).
Watanabe et al.17) reported that coronary artery lesions and 
increased serum CRP levels were significantly more common in 
patients diagnosed with both Kawasaki disease and hyponatremia. 
In the light of their findings, these authors suggested that 
hyponatremia occurs in Kawasaki disease patients having severe 
inflammation. The precise mechanisms leading to hyponatremia 
in Kawasaki disease is not known. We hypothesize that IL-1β 
and IL-6 are involved in the development of hyponatremia that 
is associated with SIADH in Kawasaki disease18).
Recently, Lim et al.14) conducted a study that supported our 
hypothesis regarding the consequences of inflammation in 
Kawasaki disease patients. These authors found that the serum 
sodium concentrations were inversely correlated with the 
percentage of neutrophils, CRP, and N-terminal-pro brain type 
natriuretic peptide levels. Additionally, serum IL-6 and IL-1β 
levels were higher in a section of Kawasaki disease patients who 
were also diagnosed with hyponatremia14). Increased levels of 
plasma ADH are found in Kawasaki disease patients diagnosed 
with SIADH14). Further, the increase in ADH concentrations 
positively correlated with the levels of IL-6 and IL-1β, suggesting 
that these cytokines may augment ADH secretion, leading to 
SIADH and hyponatremia in Kawasaki disease14).
Recently, we extended this hypothesis to a febrile urinary tract 
infection (UTI) model, and identified that hyponatremia was 
associated with renal cortical defects. Using 99m-Technetium-
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dimercaptosuccinic acid scintigraphy, we determined the serum 
sodium concentrations. The results showed that serum sodium 
concentration was negatively correlated with the white blood cell 
count (r=–0.156, P=0.011) and CRP levels (r=–0.160, P=0.028). 
Our results showed that hyponatremia is significantly correlated 
with the degree of inflammation in children with febrile UTIs19). 
Based on our findings, we suggest that hyponatremia may be 
a potential marker of severe inflammation in general19). Hypo-
natremia in febrile UTI can occur in association with other 
underlying disorders including pseudohypoaldosteronism (renal 
tubular unresponsiveness to aldosterone) and proximal tubular 
dysfunction19). SIADH also leads to hyponatremia under conditions 
of more severe inflammation by reducing the expression and 
inhibiting the function of the apical epithelial sodium channel and/
or, sodium potassium adenosine triphosphatase at the ba solateral 
membrane of renal epithelial cells via the action of proinflammatory 
cytokines such as IL-1β and tumor necrosis factor-α19).
It was suggested that patients who may be producing ADH 
due to acute inflammatory diseases or subtle volume depletion 
may be more safely treated by administering fluids that contain 
higher concentrations of sodium, by a decrease in fluid rate, or 
by employing a combination of these strategies20,21). It was also 
suggested that patients who are at risk for producing persistent 
ADH (SIADH) should receive smaller quantities of maintenance 
fluid to avoid hyponatremia. Patients with possible subtle vol-
ume depletion may receive 20 mL/kg (maximum of 1 L) of 
isotonic fluid (normal saline or Ringer lactate) over 1–2 hours 
to restore their intravascular volume22). The patient can then be 
switched to a 5% Dextrose solution in half-normal saline (0.45% 
NaCl)+20 mEq/L KCl as a standard maintenance fluid regimen, 
rather than routinely receiving fluids with 0.2% NaCl22).
Conclusions
In conclusion, available data indicate that inflammatory 
cytokines such as IL-1β and IL-6 have an important role in the 
nonosmotic release of ADH. Under inflammatory conditions, 
this mechanism may be responsible for the development of 
hyponatremia. Understanding the physiological mechanisms of 
ADH release and antidiuresis during inflammation, monitoring 
patient sodium levels, and selecting the appropriate intravenous 
fluid regimen with a suitable infusion rate will all be important 
aspects of future patient care. 
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